Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Reply
- PMID: 35648647
- DOI: 10.1097/JU.0000000000002791
Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Reply
Comment on
-
Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Letter.J Urol. 2022 Sep;208(3):566-567. doi: 10.1097/JU.0000000000002790. Epub 2022 Jun 1. J Urol. 2022. PMID: 35648648 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
